ClinicalTrials.Veeva

Menu

Long-term Follow-up of the Helsinki Businessmen Study (HBS)

H

Helsinki University Central Hospital (HUCH)

Status

Active, not recruiting

Conditions

Aging
Death
Quality of Life
Syndromes
Cardiovascular Disease

Treatments

Other: Intervention

Study type

Observational

Funder types

Other

Identifiers

NCT02526082
HBS Group

Details and patient eligibility

About

The Helsinki Businessmen Study (HBS) is a clinico-epidemiological longitudinal study started in 1964. It also included a 5-year randomized, controlled multifactorial primary prevention trial of cardiovascular diseases between 1974-1980. The cohort is being actively followed-up through national registers since the 1980, and since 2000 with regular questionnaire surveys. Latest in 2015. Also clinical and laboratory studies have been performed in random subcohorts. Follow-up is ongoing with new hypothesis-generating research questions.

Full description

The Helsinki Businessmen Study (HBS) was originally a convenient cohort of male executives and businessmen (born 1919-1934, n=3490), who participated in health check-ups between 1964-1973, but since the beginning of 1970s it has developed into a clinico-epidemiological longitudinal study. Primary focus was on the prevention of cardiovascular diseases (CVD), but since 2000 focus has been shifting to geriatrics, and with its long follow-up (up to 50 years) HBS can be seen as a "life-course" study. Traditional CVD risk factors are available from the 1960s and in 1974 participants (available n=3310) were divided in groups according to their clinical status and CVD risk. Two high-risk groups (n=1222) and low-risk group (n=593) participated in a 5-year multifactorial primary prevention study in 1974-1980 (in-trial and post-trial results have been published in 1985 and 1991). The whole original cohort has been followed-up from national registers since 1985 and with regular questionnaire surveys since 2000. Random subcohorts have been studied clinically with laboratory and genetic examinations in 2003 and 2011. The latest questionnaire survey was performed in winter 2015 by which two thirds of the original cohort had died. Follow-up of the cohort is ongoing and new research questions formulated..

Enrollment

3,490 patients

Sex

Male

Ages

31 to 46 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Participants of director studies at the Institute of Occupational Health in Helsinki, Finland, between 1964-1973

Exclusion criteria

  • Non-participants

Trial design

3,490 participants in 6 patient groups

Total, observational
Description:
Various cardiovascular risk groups described below
High-risk intervention
Description:
Healthy but at high risk in 1974
Treatment:
Other: Intervention
High-risk control
Description:
Healthy but at high risk in 1974
Low-risk conrtol
Description:
Healthy and at low risk in 1974
Sick control
Description:
Medications or clinical disease in 1974
Refused
Description:
Refused or no response in 1974

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems